CytomX Therapeutics Inc. Price to FCF Ratio 2015–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for CytomX Therapeutics Inc. (CTMX): market cap divided by trailing twelve-month free cash flow. As of September 30, 2021 it is 112.51.

From: 09/30/2015To: 03/31/2026

Stock Price

TTM Free Cash Flow

Price to FCF

CytomX Therapeutics Inc. Price to FCF Ratio — FAQ

CytomX Therapeutics Inc. (CTMX) price to fcf ratio over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CTMX's price to fcf ratio history?

The chart and table above show CytomX Therapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.